Dr Tina Soulis

[fusion_builder_container hundred_percent=”yes” overflow=”visible”][fusion_builder_row][fusion_builder_column type=”1_5″ last=”no” spacing=”yes” center_content=”no” hide_on_mobile=”no” background_color=”” background_image=”” background_repeat=”no-repeat” background_position=”left top” border_size=”0px” border_color=”” border_style=”” padding=”” margin_top=”” margin_bottom=”” animation_type=”” animation_direction=”” animation_speed=”0.1″ class=”” id=””][fusion_imageframe lightbox=”no” lightbox_image=”” style_type=”none” bordercolor=”” bordersize=”0px” borderradius=”0″ stylecolor=”” align=”none” link=”” linktarget=”_self” animation_type=”0″ animation_direction=”down” animation_speed=”0.1″ hide_on_mobile=”no” class=”” id=””] [/fusion_imageframe][/fusion_builder_column][fusion_builder_column type=”4_5″ last=”yes” spacing=”yes” center_content=”no” hide_on_mobile=”no” background_color=”” background_image=”” background_repeat=”no-repeat” background_position=”left top” border_size=”0px” border_color=”” border_style=”” padding=”” margin_top=”” margin_bottom=”” animation_type=”” animation_direction=”” animation_speed=”0.1″ class=”” id=””][fusion_text]Dr Tina Soulis

Doctor Tina Soulis is the general manager of Neuroscience Trials Australia, a wholly-owned subsidiary of the Florey Neuroscience Institutes. Tina drives the clinical development of projects for academic and commercial sponsors.

When planning your clinical trial, you can be assured it will be overseen by one of Australia’s most experienced operators in the field.

Prior to her role with Neuroscience Trials Australia, Tina was the director of clinical development at Acrux Pharma Pty Ltd. She managed the strategic direction, development, co-ordination and reporting of the company’s clinical programs. She had pivotal involvement in taking a product (Axiron), right through all stages of clinical development and in submission of the product dossier for regulatory approval.

Tina is an experienced driver of clinical drug development, particularly in the design, management and implementation of clinical trials and has worked as a clinical researcher and in senior roles within the pharmaceutical and biotechnology industry for over 20 years. Her experience encompasses all stages of drug development in many therapeutic areas and geographical regions.

Tina has held senior clinical positions with Kendle (a global CRO) that involved the leadership of projects and personnel for numerous biotechnology and pharma clients. Prior to Kendle, Tina was a post doctoral research manager responsible for a team of scientists developing new drugs for the management of diabetic disease. Tina holds a Bachelor of Science (in Biochemistry and Physiology) and a PhD in Medicine from the University of Melbourne.

Dr Tina Soulis at The Florey Institute[/fusion_text][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]